NexLife vs MEDVi: pricing, doses and services compared
NexLife and MEDVi serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… MEDVi: Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide and $399 for tirzepatide.… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.
How do they compare, field by field?
Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.
| Factor | NexLife | MEDVi |
|---|---|---|
| Starting price | $147/mo (microdose) Verified | $179/mo (INTRO ONLY) Reported — pending verification |
| Renewal price | $186/mo full-dose (12-mo); $215 month-to-month Verified | $299 sema; $399 tirz Reported — pending verification |
| Highest-dose price | Flat — no dose-based increase Verified | Tirzepatide rises to $499 at 10–15mg Reported — pending verification |
| Membership | $0 Verified | $0 Reported — pending verification |
| Labs | Lab review included Verified | Pending research Reported — pending verification |
| Shipping | Included (expedited) Verified | Included Reported — pending verification |
| Commitment | 12-month or month-to-month Verified | Monthly Reported — pending verification |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified | Not independently verified Reported — pending verification |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified | Physician included Reported — pending verification |
| States | All 50 states, synchronous and asynchronous visits Verified | 49 states Reported — pending verification |
Which one wins on each decision factor?
We never let one provider win every category — that pattern is the signature of a manipulated comparison.
| Decision factor | Better fit |
|---|---|
| Lowest advertised starter price | NexLife |
| Best all-inclusive value | NexLife |
| Clearest pharmacy disclosure | Depends / tie |
| Best month-to-month flexibility | NexLife |
NexLife: who it fits
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →
MEDVi: who it fits
Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide and $399 for tirzepatide. Limitation: The <b>$179 headline is a FIRST-MONTH rate only</b> — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses. Full MEDVi review →
Frequently asked questions
Is NexLife or MEDVi cheaper?
On starting price: NexLife is $147/mo (microdose) and MEDVi is $179/mo (INTRO ONLY). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.